Intrommune Therapeutics selected as a “Winning Startup” in The Innovate Children’s Health Challenge (ICHC) In the News / By Intrommune
Interesting Engineering: Experimental Toothpaste Might Treat Peanut Allergy In the News / By Intrommune
Research Presentations at the 2021 Annual AAAAI Meeting Highlight Limitations of Current Food Allergy Treatments and Further Validates Intrommune Therapeutics’ Approach Press Releases / By Intrommune
Chief Science Officer Erick Berglund interviewed on the Price of Business with Kevin Price In the News / By Intrommune
Intrommune Therapeutics Publishes Peanut Allergy and Immunotherapy Report Press Releases / By Intrommune
Global Data publishes profile of Intrommune Therapeutics’ Phase Ib study and its Series B raise In the News / By Intrommune
Intrommune Receives IND Clearance From U.S. Food and Drug Administration for INT301 Press Releases / By Intrommune
